co.don AG (FRA:CNW)
0.0180
+0.0045 (33.33%)
Last updated: Jun 3, 2026, 3:25 PM CET
co.don AG Revenue
In the fiscal year ending September 30, 2024, co.don AG had annual revenue of 22.00K EUR, down -99.64%.
Revenue
22.00K
Revenue Growth
-99.65%
P/S Ratio
16.40
Revenue / Employee
159.42
Employees
138
Market Cap
360.77K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 22.00K | -6.04M | -99.64% |
| Sep 30, 2023 | 6.06M | -180.33K | -2.89% |
| Sep 30, 2022 | 6.24M | -3.56M | -36.33% |
| Dec 31, 2021 | 9.80M | 3.57M | 57.28% |
| Dec 31, 2020 | 6.23M | -674.00K | -9.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 635.20M |
| Darwin AG | 54.30M |
| Paion AG | 14.81M |
| 2invest AG | 8.89M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |